Apothecon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 8.34 M
as on 07-12-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 261.53 Cr
as on 07-12-2024
- Revenue 56.32%
(FY 2022)
- Profit 123.08%
(FY 2022)
- Ebitda 11.43%
(FY 2022)
- Net Worth 23.46%
(FY 2022)
- Total Assets 10.44%
(FY 2022)
About Apothecon Pharmaceuticals
The Corporate was formerly known as Navinta Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.34 M.
The company currently has active open charges totaling ₹261.53 Cr.
Dilipkumar Parmar, Rajajeyakumar, Pankaj Parmar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232GJ2007PTC050825
- Company No.
050825
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Apothecon Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilipkumar Parmar  | Whole-Time Director | 30-Jun-2020 | Current |
| Rajajeyakumar | Whole-Time Director | 01-Jul-2017 | Current |
| Pankaj Parmar | Whole-Time Director | 01-Aug-2022 | Current |
| Jayeshkumar Joshi | Director | 15-Apr-2023 | Current |
Financial Performance of Apothecon Pharmaceuticals.
Apothecon Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.32% increase. The company also saw a substantial improvement in profitability, with a 123.08% increase in profit. The company's net worth Soared by an impressive increase of 23.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apothecon Pharmaceuticals?
In 2021, Apothecon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Oct 2024 | ₹7.22 M | Open |
State Bank Of India Creation Date: 24 Jul 2024 | ₹78.00 Cr | Open |
Hdfc Bank Limited Creation Date: 04 Sep 2023 | ₹3.94 M | Open |
How Many Employees Work at Apothecon Pharmaceuticals?
Apothecon Pharmaceuticals has a workforce of 602 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apothecon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apothecon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
